Clinical Trials Logo

Situs Inversus clinical trials

View clinical trials related to Situs Inversus.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05137873 Recruiting - Clinical trials for Great Vessels Transposition Surgery

Measurement of the Prevalence of Sensory Integration Disorders in Babies Having Heart Disease Surgery for Transposition of the Great Vessels Before 6 Months of Age

SENSOCOEUR
Start date: April 14, 2022
Phase:
Study type: Observational

The purpose of this study is to mesure the prevalence of severe sensory integration disorders in babies after one week of their heart surgery.

NCT ID: NCT04616222 Recruiting - Clinical trials for Transposition of Great Vessels

A Retrospective Comparison of the Efficacy and Safety of Celsior® in Pediatric Cardiac Surgery for Transposition of the Great Vessels

CELSIOR-TGV
Start date: September 1, 2020
Phase:
Study type: Observational

Celsior® is an organ preservation solution used for the harvesting and the preservation of solid organs. Its use as a crystalloid cardioplegia solution has been established recently. Its main advantage is the long duration of myocardial protection. Compared to the other cardioplegia solutions, it allows a reduced amount of solution administered during the surgery and fewer interruptions during the intervention for the administration of supplemental doses of cardioplegia for long and complex operations. The objective of this register is to compare the safety and the efficacy of Celsior® to the old cardioplegia solution Saint-Thomas used as cardioplegia solution in surgery of the transposition of great vessels, the arterial switch operation.

NCT ID: NCT03771534 Recruiting - Clinical trials for TGA - Transposition of Great Arteries

Acute Maternal Hyperoxygenation for Fetal Transposition of the Great Arteries (TGA)

Start date: September 20, 2018
Phase: N/A
Study type: Interventional

This prospective study will examine whether transient maternal hyperoxygenation is useful as a diagnostic test to more accurately detect TGA patients with poor vs. good neonatal intra-cardiac mixing of blood, based on the in-utero response to oxygen exposure. This study is Health Canada regulated